Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP) and Molina Healthcare (MOH)

Tipranks - Wed Feb 11, 2:10AM CST

Analysts are pulling back from the Healthcare sector as 2 experts expressed today bearish sentiments on Medpace Holdings (MEDPResearch Report) and Molina Healthcare (MOHResearch Report).

Valentine's Day Sale - 70% Off

Medpace Holdings (MEDP)

Barclays analyst Luke Sergott maintained a Sell rating on Medpace Holdings today and set a price target of $525.00. The company’s shares closed last Monday at $530.35.

According to TipRanks.com, Sergott is a 1-star analyst with an average return of -1.6% and a 42.7% success rate. Sergott covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Fortrea Holdings Inc., and Pacific Biosciences. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Medpace Holdings with a $585.00 average price target.

See the top stocks recommended by analysts >>

Molina Healthcare (MOH)

Barclays analyst Andrew Mok CFA maintained a Sell rating on Molina Healthcare today and set a price target of $133.00. The company’s shares closed last Monday at $127.53.

According to TipRanks.com, CFA is a 1-star analyst with an average return of -1.2% and a 50.4% success rate. CFA covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Alignment Healthcare. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Molina Healthcare with a $175.55 average price target, representing a 33.0% upside. In a report issued on February 6, Bank of America Securities also reiterated a Sell rating on the stock with a $145.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.